{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T20:53:46Z","timestamp":1761512026189},"reference-count":15,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2005,4,1]],"date-time":"2005-04-01T00:00:00Z","timestamp":1112313600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Lung Cancer"],"published-print":{"date-parts":[[2005,4]]},"DOI":"10.1016\/j.lungcan.2004.10.006","type":"journal-article","created":{"date-parts":[[2004,12,22]],"date-time":"2004-12-22T09:39:20Z","timestamp":1103708360000},"page":"129-135","source":"Crossref","is-referenced-by-count":24,"title":["Phase II trial of oral vinorelbine in combination with cisplatin followed by consolidation therapy with oral vinorelbine in advanced NSCLC"],"prefix":"10.1016","volume":"48","author":[{"given":"M. De","family":"Lena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Ramlau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Lorusso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Barni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.M.","family":"Cristovao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Huber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"Alberola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Mitrovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Colin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Gasmi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.lungcan.2004.10.006_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1200\/JCO.2004.09.053","article-title":"American society of clinical oncology treatment of unresectable non-small-cell lung cancer guideline. Update 2003","volume":"22","author":"Pfister","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib2","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1200\/JCO.2001.19.5.1336","article-title":"Duration of Chemotherapy in advanced non-small-cell lung cancer: a randomised trial of three versus six courses of mitomycin, vinblastine, and cisplatin","volume":"19","author":"Smith","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1093\/oxfordjournals.annonc.a058687","article-title":"Vinorelbine versus vinorelbine plus cisplatin in advanced NSCLC; a randomized trial","volume":"5","author":"Depierre","year":"1994","journal-title":"Ann Oncol"},{"issue":"2","key":"10.1016\/j.lungcan.2004.10.006_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1200\/JCO.1994.12.2.360","article-title":"Randomised study of vinorelbine and cisplatin versus vindesine and cisplatin and vinorelbine alone in advanced non-small cell lung cancer; results of a European multicenter trial including 612 patients","volume":"12","author":"Le Chevalier","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib5","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1093\/annonc\/mdf316","article-title":"GLOB 1: a phase III trial comparing the combination of vinorelbine and cisplatin (NP) versus vinorelbine, ifosfamide and cisplatin (NIP) in metastatic non-small cell lung cancer patients (NSCLC)","volume":"13","author":"Souquet","year":"2002","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.lungcan.2004.10.006_bib6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1200\/JCO.1998.16.7.2459","article-title":"Randomized trial comparing cisplatin with cisplatin plus vinorelbine in the treatment of advanced non-small cell lung cancer","volume":"16","author":"Wozniak","year":"1998","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib7","doi-asserted-by":"crossref","first-page":"3210","DOI":"10.1200\/JCO.2001.19.13.3210","article-title":"Randomized phase III trial of paclitaxel plus carboplatin versus vinorelbine plus cisplatin in the treatment of patients with advanced non-small-cell lung cancer. A southwest oncology group trial","volume":"19","author":"Kelly","year":"2001","journal-title":"J Clin Oncol"},{"issue":"21","key":"10.1016\/j.lungcan.2004.10.006_bib8","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1200\/JCO.2002.02.068","article-title":"Phase III randomized trial comparing three platinum-based doublets in advanced non-small-cell lung cancer","volume":"20","author":"Scagliotti","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib9","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1023\/A:1012539225493","article-title":"A multicenter randomised phase II study of oral versus intravenous vinorelbine in advanced non-small cell lung cancer patients","volume":"12","author":"Jassem","year":"2001","journal-title":"Ann Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib10","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/annonc\/mdg455","article-title":"Oral vinorelbine in combination with cisplatin; a novel activeregimen in advanced non-small cell lung cancer","volume":"14","author":"Jassem","year":"2003","journal-title":"Ann Oncol"},{"issue":"1","key":"10.1016\/j.lungcan.2004.10.006_bib11","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1200\/JCO.1997.15.1.110","article-title":"Patient preferences for oral versus intravenous palliative chemotherapy","volume":"15","author":"Liu","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.lungcan.2004.10.006_bib12","unstructured":"WHO handbook for reporting results in cancer treatment. World Heath Organisation. Geneva, Switzerland; 1979."},{"key":"10.1016\/j.lungcan.2004.10.006_bib13","unstructured":"Common Toxicity Criteria, version 2.0. National Cancer Institute. Bethesda, MD; 1999."},{"key":"10.1016\/j.lungcan.2004.10.006_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2307\/2530297","article-title":"One\u2013sample multiple testing procedure for phase II clinical trials","volume":"38","author":"Fleming","year":"1982","journal-title":"Biometrics"},{"issue":"suppl 2","key":"10.1016\/j.lungcan.2004.10.006_bib15","first-page":"0","article-title":"Phase III trial Comparing cisplatin (CDDP) plus weekly vinorelbine (VNR) and CDDP plus day 1+8 VNR schedules in advanced non smallcell lung cancer (NSCLC)","volume":"41","author":"Gebbia","year":"2003","journal-title":"Lung Cancer"}],"container-title":["Lung Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020400532X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016950020400532X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,30]],"date-time":"2019-01-30T13:27:58Z","timestamp":1548854878000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016950020400532X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,4]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2005,4]]}},"alternative-id":["S016950020400532X"],"URL":"https:\/\/doi.org\/10.1016\/j.lungcan.2004.10.006","relation":{},"ISSN":["0169-5002"],"issn-type":[{"value":"0169-5002","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4]]}}}